Small Molecule Wnt Pathway Inhibitor (SM04755) as a Potential Topical Psoriasis Treatment
April 2017
in “
Journal of Investigative Dermatology
”
Wnt signaling pathway SM04755 pro-inflammatory cytokine monocytes PBMCs cytokine-induced keratinocyte proliferation fibrosis markers human dermal fibroblasts clobetasol T cell activation cytokine secretion Wnt pathway small-molecule inhibitor inflammation white blood cells peripheral blood mononuclear cells skin cell growth skin fibrosis skin cells steroid cream immune cells immune response
Studysummary This study found that SM04755, a novel topical drug, inhibited inflammation, keratinocyte proliferation, and fibrosis in vitro and improved skin health in a mouse model of psoriasis, indicating potential as a topical psoriasis treatment.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer